Compass Files Psilocybin Application with FDA, U.S. Government Taps Mark Cuban to Develop Ibogaine, Psychedelics After the Midterms
From The Psychedelic News Feed · 14:25
Show by Psychedelic Alpha
In this episode of The Psychedelic News Feed podcast, Psychedelic Alpha’s editor Josh Hardman runs through the last two weeks in the psychedelics field, including these stories:Compass Pathways submits its psilocybin new drug application to FDAWe look at what the midterms might mean for the psychedelics fieldU.S. government taps Mark Cuban to support ibogaine research pushDelix Therapeutics raises $100M Series COther storiesRead more:Breaking: Compass Files Psilocybin for TRD New Drug Application with FDAPα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial DateBreaking: U.S. Government Taps Mark Cuban’s Company to Develop Ibogaine for PTSD; Commits to Fund $20M Real-World Evidence Network220 Patients or 20,000? Clinics Split on Psychedelics’ First Year The Psychedelic News Feed is published by Psychedelic Alpha and airs every two weeks.This episode of The Psychedelic News Feed is supported by UBC. As psychedelic therapies move toward potential approvals, UBC helps sponsors navigate the evidence generation, pharmacovigilance, and comprehensive risk management strategies that support a path forward grounded in patient safety. Learn more at ubc.com.Send us your questions and comments at [email protected] Read more and join our newsletter at https://psychedelicalpha.comFollow us on Instagram @psychedelicalpha, X @Psyched_Alpha, and LinkedIn.Subscribe to Pα+ for premium insights: https://psychedelicalpha.com/join/
More episodes of The Psychedelic News Feed
More episodes
- Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
- Early Healthcare Forum Takeaways, FDA’s Ibogaine Blueprint, and Compass Talks Pricing
- Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
- Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.